Astrazeneca Equities

AstraZeneca's Dato-DXd Fails to Meet Survival Endpoint in Breast Cancer Trial Sep 23, 2024

Amgen and AstraZeneca Showcase Efficacy of Tezspire in Treating COPD Across Diverse Patients May 21, 2024